Estimation of kidney function in patients with cancer directly affects drug dosing, agent
selection, and eligibility for clinical trials of novel agents. Overestimation of kidney function …

The prevalence of CKD may be higher in patients with cancer than in those without due to
the addition of cancer-specific risk factors to those already present for CKD. In this review …

A precise and efficient method for estimating kidney function in cancer patients is important
to determine their eligibility for clinical trials and surgeryáand to allow for appropriate dose …

Monitoring renal function in patients with solid tumors and hematologic malignancies is vital
to the safe administration of therapeutic agents. Renal impairment is frequent in elderly …

Abstract Purpose Creatinine clearance (Ccr) is used as a marker of renal function in cancer
chemotherapy, but it is not correlated with glomerular filtration rate (GFR) after high-dose …

Background Oncology clinicians are now routinely provided with an estimated glomerular
filtration rate on pathology reports whenever serum creatinine is requested. The utility of …

Background Assessment of renal function is important for safe cancer chemotherapy, and
eligibility criteria for clinical trials often include creatinine clearance. However, creatinine …

Cancer patients are living longer. The sequelae of cancer treatment and the role of comorbid
conditions present before the diagnosis, such as CKD, have been increasingly recognized …

MODERN THERAPEUTICS emphasizes regimen individ-ualization to maximize benefit
while minimizing adverse drug effects. Adjustment of a maintenance dose by interval …

Background: More elderly patients are being treated with chemotherapy. Reliable and
accurate measures of renal function are needed to obtain predictable, safe and effective …